Skip to main content
Top
Published in: Journal of General Internal Medicine 2/2008

01-02-2008 | Case Reports/Clinical Vignettes

Pseudohyponatremia in a Patient with HIV and Hepatitis C Coinfection

Authors: Brian T. Garibaldi, Scott J. Cameron, Michael Choi

Published in: Journal of General Internal Medicine | Issue 2/2008

Login to get access

Abstract

Pseudohyponatremia refers to low serum sodium in the presence of normal plasma tonicity. Whereas pseudohyponatremia secondary to hyperlipidemia is a commonly recognized occurrence, falsely low sodium levels secondary to elevated protein are less frequently observed. We present in this paper the case of a man coinfected with HIV and hepatitis C who had pseudohyponatremia from hypergammaglobulinemia. As hypergammaglobulinemia is a frequent occurrence in both HIV and HCV, we suggest that pseudohyponatremia is an important and likely underdiagnosed phenomenon in this patient population. Clinicians need to be aware of the electrolyte exclusion effect and become familiar with the techniques used by their local laboratory in the measurement of serum electrolytes. Pseudohyponatremia should also be included in the differential diagnosis of an elevated osmolal gap, as the falsely lowered sodium level will lead to a falsely low calculated serum osmolality.
Literature
1.
go back to reference Tietz NW, Pruden EL, Siggaard-Andersen O. Electrolytes. In: Burtis CA, Ashwood ER, eds. Tietz Fundamental of Clinical Chemistry, 4th ed. Philadelphia, PA: WB Saunders; 1996:497–505. Tietz NW, Pruden EL, Siggaard-Andersen O. Electrolytes. In: Burtis CA, Ashwood ER, eds. Tietz Fundamental of Clinical Chemistry, 4th ed. Philadelphia, PA: WB Saunders; 1996:497–505.
2.
go back to reference Nguyen MK, Ornekian V, Butch AW, Kurtz I. A new method for determining plasma water content: application in pseudohyponatremia. Am J Physiol Renal Physiol. 2007;292(5):F1652–6.PubMedCrossRef Nguyen MK, Ornekian V, Butch AW, Kurtz I. A new method for determining plasma water content: application in pseudohyponatremia. Am J Physiol Renal Physiol. 2007;292(5):F1652–6.PubMedCrossRef
5.
go back to reference Frier BM, Steer CR, Baird JD, Bloomfield S. Misleading plasma electrolytes in diabetic children with severe hyperlipidaemia. Arch Dis Child. 1980;55:771–5.PubMedCrossRef Frier BM, Steer CR, Baird JD, Bloomfield S. Misleading plasma electrolytes in diabetic children with severe hyperlipidaemia. Arch Dis Child. 1980;55:771–5.PubMedCrossRef
6.
go back to reference Waugh WH. Utility of expressing serum sodium per unit of water in assessing hyponatremia. Metabolism. 1969;18(8):706–12.PubMedCrossRef Waugh WH. Utility of expressing serum sodium per unit of water in assessing hyponatremia. Metabolism. 1969;18(8):706–12.PubMedCrossRef
7.
go back to reference Grateau G, Bachmeyer C, Taulera O, Sarfati G, Cremer G, Sereni D. Pseudohyponatremia and pseudohyperphosphatemia in a patient with human immunodeficiency virus infection. Nephron. 1993;64(4):640.PubMed Grateau G, Bachmeyer C, Taulera O, Sarfati G, Cremer G, Sereni D. Pseudohyponatremia and pseudohyperphosphatemia in a patient with human immunodeficiency virus infection. Nephron. 1993;64(4):640.PubMed
8.
go back to reference Abelian A, Burling K, Easterbrook P, Winter G. Hyperimmunoglobulinemia and rate of HIV type 1 infection progression. AIDS Res Hum Retroviruses. 2004;20(1):127–8.PubMedCrossRef Abelian A, Burling K, Easterbrook P, Winter G. Hyperimmunoglobulinemia and rate of HIV type 1 infection progression. AIDS Res Hum Retroviruses. 2004;20(1):127–8.PubMedCrossRef
9.
go back to reference Shirai A, Cosentino M, Leitman-Klinman S, Klinman D. Human immunodeficiency virus infection induces both polyclonal and virus-specific B cell activation. J Clin Invest. 1992;89(2):561–6.PubMedCrossRef Shirai A, Cosentino M, Leitman-Klinman S, Klinman D. Human immunodeficiency virus infection induces both polyclonal and virus-specific B cell activation. J Clin Invest. 1992;89(2):561–6.PubMedCrossRef
10.
go back to reference Binley JM, Klasse PJ, Cao Y, Jones I, Markowitz M, Ho DD, Moore JP. Differential regulation of the antibody responses to Gag and Env proteins of human immunodeficiency virus type 1. J Virol. 1997;71(4):2799–809.PubMed Binley JM, Klasse PJ, Cao Y, Jones I, Markowitz M, Ho DD, Moore JP. Differential regulation of the antibody responses to Gag and Env proteins of human immunodeficiency virus type 1. J Virol. 1997;71(4):2799–809.PubMed
11.
go back to reference Morris L, Binley JM, Clas BA, et al. HIV-1 antigen-specific and -nonspecific B cell responses are sensitive to combination antiretroviral therapy. J Exp Med. 1998;188(2):233–45.PubMedCrossRef Morris L, Binley JM, Clas BA, et al. HIV-1 antigen-specific and -nonspecific B cell responses are sensitive to combination antiretroviral therapy. J Exp Med. 1998;188(2):233–45.PubMedCrossRef
12.
go back to reference Genesca J, Gonzalez A, Torregrosa M, Mujal A, Segura R. High levels of endotoxin antibodies contribute to hyperglobulinemia of cirrhotic patients. Am J Gastroenterol. 1998;93(4):664–5.PubMedCrossRef Genesca J, Gonzalez A, Torregrosa M, Mujal A, Segura R. High levels of endotoxin antibodies contribute to hyperglobulinemia of cirrhotic patients. Am J Gastroenterol. 1998;93(4):664–5.PubMedCrossRef
13.
go back to reference Morsica G, Tambussi G, Sitia G, et al. Replication of hepatitis C virus in B lymphocytes (CD19+). Blood. 1999;94(3):1138–9.PubMed Morsica G, Tambussi G, Sitia G, et al. Replication of hepatitis C virus in B lymphocytes (CD19+). Blood. 1999;94(3):1138–9.PubMed
14.
go back to reference Zignego AL, Brechot C. Extrahepatic manifestations of HCV infection: facts and controversies. J Hepatol. 1999;31(2):369–76.PubMedCrossRef Zignego AL, Brechot C. Extrahepatic manifestations of HCV infection: facts and controversies. J Hepatol. 1999;31(2):369–76.PubMedCrossRef
15.
go back to reference Soriano-Sarabia N, Leal M, Delgado C, et al. Effect of hepatitis C virus coinfection on humoral immune alterations in naive HIV-infected adults on HAART: a three year follow-up study. J Clin Immunol. 2005;25(3):296–302.PubMedCrossRef Soriano-Sarabia N, Leal M, Delgado C, et al. Effect of hepatitis C virus coinfection on humoral immune alterations in naive HIV-infected adults on HAART: a three year follow-up study. J Clin Immunol. 2005;25(3):296–302.PubMedCrossRef
Metadata
Title
Pseudohyponatremia in a Patient with HIV and Hepatitis C Coinfection
Authors
Brian T. Garibaldi
Scott J. Cameron
Michael Choi
Publication date
01-02-2008
Publisher
Springer-Verlag
Published in
Journal of General Internal Medicine / Issue 2/2008
Print ISSN: 0884-8734
Electronic ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-007-0446-3

Other articles of this Issue 2/2008

Journal of General Internal Medicine 2/2008 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine